Clinical Trials Directory

Trials / Completed

CompletedNCT03312478

Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes

To Evaluate the Association Between Type 1 Diabetes Mellitus (T1DM) in Offspring With Positive Parental History of Diabetes

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
375 (actual)
Sponsor
Sanofi · Industry
Sex
All
Age
2 Years – 20 Years
Healthy volunteers
Accepted

Summary

Primary Objective: To measure the association between a parental history of diabetes and the odds of an offspring being Type 1 diabetics. Secondary Objectives: * To document the profile of Type 1 diabetes patients. * To document the glycemic parameters (Fasting blood glucose \[FBG\] and glycosylated hemoglobin \[HbA1c\]) of Type 1 diabetes. * To capture the current therapeutic management.

Detailed description

The overall duration of this study is expected to be 12 months. The recruitment period for a given center will be four months following site initiation of that center. telephonic follow-up for all the patients shall be conducted after 15 days ± 5 days. \*Each patient (cases as well as controls) will be required to undergo laboratory tests for insulin autoantibodies and hemoglobin A1c tests. Both the tests will be conducted through centralized laboratories for all recruited patients. Since the result of insulin auto-antibodies test is one of the inclusion criteria, it is mandatory for all patients to undergo this test, and detailed information for the same has been included in the informed consent form.

Conditions

Interventions

TypeNameDescription
DRUGBlood draw for insulin auto-anti body tests*Pharmaceutical form: N/A Route of administration: N/A

Timeline

Start date
2017-10-13
Primary completion
2018-08-19
Completion
2018-08-19
First posted
2017-10-17
Last updated
2022-04-25

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT03312478. Inclusion in this directory is not an endorsement.